Company announces new CEO, Chief Commercial Officer, and Chief Technology Officer
- David McNally named CEO of Xenocor.
- Antony Watson appointed as Chief Commercial Officer.
- David Van Ness becomes Chief Technology Officer.
Xenocor has announced a significant shift in its leadership team, appointing David McNally as Chief Executive Officer. This move aims to strengthen the company's direction in the medical technology sector. Under his leadership, Xenocor seeks to enhance its innovative approach and market presence.
In addition to McNally's new role, Antony Watson has been named Chief Commercial Officer, while David Van Ness will serve as Chief Technology Officer. These appointments are part of a broader strategy to propel Xenocor's growth and technological advancements within the medical field.
These leadership changes come at a pivotal time for the company as it continues to focus on developing its products. The new executives are expected to bring valuable experience and insights to drive Xenocor's future initiatives and partnerships.
